Journal
PLoS One
Publication Date
1-1-2023
Volume
18
Issue
12
First Page
e0293700
Document Type
Open Access Publication
DOI
10.1371/journal.pone.0293700
Rights and Permissions
Fontana F, Esser AK, Egbulefu C, Karmakar P, Su X, Allen JS, Xu Y, Davis JL, Gabay A, Xiang J, Kwakwa KA, Manion B, Bakewell S, Li S, Park H, Lanza GM, Achilefu S, Weilbaecher KN. Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting. PLoS One. 2023 Dec 20;18(12):e0293700. doi: 10.1371/journal.pone.0293700. © 2023 Fontana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Citation
Fontana, Francesca; Esser, Alison K.; Egbulefu, Christopher; Karmakar, Partha; Su, Xinming; Allen, John S.; Xu, Yalin; Davis, Jennifer L.; Gabay, Ariel; Xiang, Jingyu; Kwakwa, Kristin A.; Manion, Brad; Bakewell, Suzanne; Li, Shunqiang; Park, Haeseong; Lanza, Gregory M.; Achilefu, Samuel; and Weilbaecher, Katherine N., "Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting." PLoS One. 18, 12. e0293700 (2023).
https://digitalcommons.wustl.edu/oa_4/3024
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
